• 30+ years in biomedical research:
    • Biotechnology consulting
    • Major pharmaceutical R&D
    • Academic research and administration
    • Biomedical engineering
  • Leader of international collaborative research projects involving academic and pharmaceutical scientists
  • Senior manager of multidisciplinary groups of scientists responsible for the discovery of novel agents for the prevention and treatment of cardiovascular diseases
  • Key contributor to major regulatory filings for novel compounds or approaches
  • Author of over 150 publications, invited reviews, and abstracts in cardiovascular research, specializing in cardiovascular physiology and pharmacology
  • Co-inventor on two patents
  • Reviewer for major life science journals
  • Professional societies:
    • American Society for Pharmacology and Experimental Therapeutics: Division of Drug Discovery and Development Past Chair
    • American Heart Association: Fellow
  • Leader/Co-Leader of global scientific, strategic, and licensing teams
  • Internal Animal Care and Use Committee Member
  • Reviewer of academic (NIH SBIR/STTR) and community grant applications
  • Academic administrator (Dean) overseeing occupational programs and economic development, including a local Small Business Development Center

Professional Background

  • President, Lead BioPharma Consulting, LLC
  • Sr. Director, Pfizer Global R&D
  • Section Manager, Sanofi Pharmaceuticals
  • Biomedical Engineer, St. Luke's Hospital


  • Ph.D., Physiology, University of Kansas
  • Postdoctoral Fellowship, The Upjohn Company
  • M.B.A., St. Joseph's University
  • M.S., Biomedical Engineering, University of Wisconsin
  • B.S., Medical Technology, Michigan State University


  • Scientific and business development consultant for domestic and international biotechnology, pharmaceutical, and medical device companies
  • Out-licensing support for biotechs
  • Licensing and due diligence for major pharmaceutical companies
  • Business development and marketing for CROs
  • Regulatory filings for a novel biotherapeutic agent
  • Scientific Advisor for development of novel medical devices
  • Consultant for venture capital organizations evaluating investment opportunities
  • Chair, NIH Bioengineering Sciences and Technologies (BST-T[90]) Study Section
  • NIH SBIR and SMART grant writing assistance for funded projects
  • NIH SBIR/STTR Special Emphasis Review Panels—Cardiovascular Sciences Small Business Activities
  • Department of Defense SBIR grant writing assistance for funded projects
  • Presentations and session Chair at international scientific meetings (e.g., American Heart Association, Experimental Biology, and Canadian Cardiology Conference)
  • Mentor, Ann Arbor Spark "Shifting Gears"
  • Workforce development US Department of Labor and State of Michigan grants